Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Gerber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Molecular Sciences|November 11, 2022
Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital WartsStephan A Braun, Alexander T Bauer, Csongor Németh, et al.
Science Translational Medicine|August 23, 2013
Epidermal EGFR controls cutaneous host defense and prevents inflammationBeate M Lichtenberger, Peter A Gerber, Martin Holcmann, et al.
Allergy|July 4, 2019
Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse eventsHeike C Hawerkamp, Andreas Kislat, Peter A Gerber, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expressionAndor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Molecular Sciences|November 11, 2022
Immunothrombotic Mechanisms Induced by Ingenol Mebutate Lead to Rapid Necrosis and Clearance of Anogenital WartsStephan A Braun, Alexander T Bauer, Csongor Németh, et al.
Science Translational Medicine|August 23, 2013
Epidermal EGFR controls cutaneous host defense and prevents inflammationBeate M Lichtenberger, Peter A Gerber, Martin Holcmann, et al.
Allergy|July 4, 2019
Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse eventsHeike C Hawerkamp, Andreas Kislat, Peter A Gerber, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expressionAndor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Pageof 2